首页> 美国卫生研究院文献>Scientific Reports >Repair of osteochondral defects with in vitro engineered cartilage based on autologous bone marrow stromal cells in a swine model
【2h】

Repair of osteochondral defects with in vitro engineered cartilage based on autologous bone marrow stromal cells in a swine model

机译:猪模型中基于自体骨髓基质细胞的体外工程软骨修复骨软骨缺损

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Functional reconstruction of large osteochondral defects is always a major challenge in articular surgery. Some studies have reported the feasibility of repairing articular osteochondral defects using bone marrow stromal cells (BMSCs) and biodegradable scaffolds. However, no significant breakthroughs have been achieved in clinical translation due to the instability of in vivo cartilage regeneration based on direct cell-scaffold construct implantation. To overcome the disadvantages of direct cell-scaffold construct implantation, the current study proposed an in vitro cartilage regeneration strategy, providing relatively mature cartilage-like tissue with superior mechanical properties. Our strategy involved in vitro cartilage engineering, repair of osteochondral defects, and evaluation of in vivo repair efficacy. The results demonstrated that BMSC engineered cartilage in vitro (BEC-vitro) presented a time-depended maturation process. The implantation of BEC-vitro alone could successfully realize tissue-specific repair of osteochondral defects with both cartilage and subchondral bone. Furthermore, the maturity level of BEC-vitro had significant influence on the repaired results. These results indicated that in vitro cartilage regeneration using BMSCs is a promising strategy for functional reconstruction of osteochondral defect, thus promoting the clinical translation of cartilage regeneration techniques incorporating BMSCs.
机译:大骨软骨缺损的功能重建一直是关节外科手术中的主要挑战。一些研究报告了使用骨髓基质细胞(BMSC)和可生物降解的支架修复关节软骨软骨缺损的可行性。然而,由于基于直接细胞支架构建体植入的体内软骨再生的不稳定性,在临床翻译中没有取得重大突破。为了克服直接将细胞支架构建体植入的弊端,当前的研究提出了一种体外软骨再生策略,该方法可提供具有优良机械性能的相对成熟的软骨样组织。我们的策略涉及体外软骨工程,骨软骨缺损的修复以及体内修复功效的评估。结果表明BMSC体外工程软骨(BEC-vitro)呈现出时间依赖性的成熟过程。单独植入BEC体外可以成功实现软骨和软骨下骨的组织特异性骨软骨缺损修复。此外,BEC体外的成熟水平对修复结果有重要影响。这些结果表明,使用BMSCs进行体外软骨再生是骨软骨缺损功能重建的有前途的策略,从而促进了结合BMSCs的软骨再生技术的临床翻译。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号